UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 18, 2008

BioCryst Pharmaceuticals, Inc.
(Exact name of registrant as specified in its charter)
         
DELAWARE   000-23186   62-1413174
(State or other Jurisdiction of Incorporation)   (Commission File Number)   (IRS Employer Identification No.)
     
2190 Parkway Lake Drive, Birmingham, Alabama
  35244
(Address of Principal Executive Offices)   (Zip Code)

Registrant’s telephone number, including area code: (205) 444-4600
 
NOT APPLICABLE
(Former name or former address if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 
 

 

1

 

Item 9.01. Financial Statements and Exhibits.

The following document extends the period of the SWO until November 17, 2008. It is being filed with this Form 8-K solely because it was inadvertently omitted from our Form 10-Q filed on October 31, 2008. The total contract amount remains unchanged ($102,661,429). The contract completion date remains unchanged (December 31, 2010).

     
Exhibit    
Number   Description
10.1
  Amendment of Solicitation/Modification of Contract.

 

2

 

 
SIGNATURE
 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 
 

             
        BioCryst Pharmaceuticals, Inc.
         
 
           
Date:
  November 7, 2008   By:   /s/ Michael A. Darwin
 
         
 
      Name:   Michael A. Darwin
 
      Title:   Vice President Finance
 
         
 

 

3

 

EXHIBIT INDEX

     
Exhibit    
Number   Description
10.1
  Amendment of Solicitation/Modification of Contract.

 

4

Exhibit 10.1
                             
AMENDMENT OF SOLICITATION/MODIFICATION OF CONTRACT
  1. CONTRACT ID CODE   PAGE OF PAGES
 
                  1   1    
2. AMENDMENT/MODIFICATION NO:
      3. EFFECTIVE DATE   4. REQUISITION/PURC   5. PROJECT NO. ( If applicable )        
Six (6)
      See block 16C   N/A     N/A          
6. ISSUED BY
  CODE       7. ADMINISTERED BY ( If other then Item 6 )   CODE        
 
                           
Office of Preparedness and Response
                           
Biomedical Advanced Research and Development Authority
                   
U.S. Department of Health and Human Services
                   
330, Independence Avenue, SW Room G640
                   
Washington, DC 20201
                           
                 
8. NAME AND ADDRESS OF CONTRACTOR ( No., street, county, State and ZIP Code )       9A. AMENDMENT OF SOLICITATION NO.
 
               
BioCryst Pharmaceuticals, Inc.
              9B. DATED ( SEE ITEM 11 )
2190 Parkway Lake Drive
               
Birmingham, AL 35244
               
DUNS 61-819-4609
               
TIN 62-1413174
              10A. MODIFICATION OF CONTRACT/ORDER
           HHSO100200700032C
CODE
    FACILITY CODE   X   10B. DATED ( SEE ITEM 13)
01-03-07
    11. THIS ITEM ONLY APPLIES TO AMENDMENTS OF SOLICITATIONS
~ The above numbered solicitation is amended as set forth in Item 14. The hour and date specified for receipt of Offers ~ is extended, ~ is not extended.

Offers must acknowledge receipt of this amendment prior to the hour and date specified in the solicitation or as amended, by one of the following methods: (a) By completing Items 8 and 15, and returning                      copies of the amendment; (b) By acknowledging receipt of this amendment on each copy of the offer submitted; or (c) By separate letter or telegram which Includes a reference to the solicitation and amendment numbers. FAILURE OF YOUR ACKNOWLEDGEMENT TO BE RECEIVED AT THE PLACE DESIGNATED FOR THE RECEIPT OF OFFERS PRIOR TO THE HOUR AND DATE SPECIFIED MAY RESULT IN REJECTION OF YOUR OFFER. If by virtue of this amendment, you desire to change an offer already submitted, such change may be made by telegram or letter, provided each telegram or letter makes reference to the solicitation and this amendment, and is received prior to the opening hour and date specified.
12. ACCOUNTING AND APPROPRIATION DATA ( If required )
SOCC:
  DOC#   TIN#   LOC#   CAN#
13. THIS ITEM APPLIES ONLY TO MODIFICATIONS OF CONTRACTS/ORDERS; IT MODIFIES THE CONTRACT/ORDER NO. AS DESCRIBED IN ITEM 14.
 
 
  A.   THIS CHANGE ORDER IS ISSUED PURSUANT TO: ( Specify authority) THE CHANGES SET FORTH IN ITEM 14 ARE MADE IN THE CONTRACT ORDER NO. IN ITEM 10A.
 
       
 
  B.   THE ABOVE NUMBERED CONTRACT/ORDER IS MODIFIED TO REFLECT THE ADMINISTRATIVE CHANGES ( such as changes in paying office, appropriation date, etc.) SET FORTH IN ITEM 14, PURSUANT TO THE AUTHORITY OF FAR 43.103(b).
 
X
  C.   THIS SUPPLEMENTAL AGREEMENT IS ENTERED INTO PURSUANT TO AUTHORITY OF:
FAR 1.602-1, FAR 52.242-15 Stop-Work Order
 
 
  D.   OTHER ( Specify type of modification and authority )
E. IMPORTANT: Contractor o is not, þ is required to sign this document and return 2 copies to the issuing office.
 
14. DESCRIPTION OF AMENDMENT/MODIFICATION ( Organized by UCF section headings, including solicitation/contract subject matter where feasible )
PURPOSE: The purpose of this modification is to:
  1.   Extend the period of the Stop-Work Order for an additional 90 days until November 17, 2008.
The total contract amount remains unchanged. ($102,661,429)
The contract completion date remains unchanged. (December 31, 2010)
Except as provided herein, all terms and conditions referenced in item 9A or 10A, as heretofore changed, remains full force and effect.
     
15A. NAME AND TITLE OF SIGNER ( Type or print )
  16A. NAME AND TITLE OF CONTRACTING OFFICER ( Type or print )
 
   
Michael A. Darwin, VP Finance
  Schuyler T. Eldridge
                 
15B. CONTRACTOR/OFFEROR   15C. DATE SIGNED   16B. UNITED STATES OF AMERICA   16C. DATE SIGNED
 
               
/s/ Michael A. Darwin
 
( Signature of person authorized to sign )
  8/18/08    BY   /s/ Schuyler T. Eldridge
 
( Signature of Contracting Officer ) 		  8/18/08 
         
NSN 7540-01-152-8070
  OMB No. 0990—0115   STANDARD FORM 30 (REV. 10-83)